Ubs Group Ag Amgen Inc Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Amgen Inc stock. As of the latest transaction made, Ubs Group Ag holds 77,000 shares of AMGN stock, worth $23.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

77,000

Previous 3,360,528 97.71%

Holding current value

$23.6 Million

Previous $968 Million 97.74%

% of portfolio

0.01%

Previous 0.29%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $104 Million - $126 Million	387,082 Added 11.52%	3,747,610 $1.07 Billion
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $114 Million - $128 Million	444,008 Added 15.22%	3,360,528 $968 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $73.2 Million - $90.9 Million	-334,740 Reduced 10.3%	2,916,520 $784 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $113 Million - $134 Million	-527,937 Reduced 13.97%	3,251,260 $722 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $14.4 Million - $17.6 Million	-63,945 Reduced 1.66%	3,779,197 $914 Million

Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $111 Million - $142 Million	486,697 Added 14.5%	3,843,142 $1.01 Billion
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $50.3 Million - $56.7 Million	-224,009 Reduced 6.26%	3,356,445 $757 Million
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $22.4 Million - $24.9 Million	-96,915 Reduced 2.64%	3,580,454 $871 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $23 Million - $25.5 Million	-104,939 Reduced 2.77%	3,677,369 $889 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $10.5 Million - $12 Million	-52,893 Reduced 1.38%	3,782,308 $851 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $23 Million - $27 Million	108,502 Added 2.91%	3,835,201 $816 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $81 Million - $89.8 Million	346,659 Added 10.26%	3,726,699 $908 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $30.4 Million - $35.5 Million	137,148 Added 4.23%	3,380,040 $841 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $194 Million - $231 Million	897,628 Added 38.27%	3,242,892 $746 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $19.9 Million - $22.1 Million	84,739 Added 3.75%	2,345,264 $596 Million
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $45 Million - $55.3 Million	-227,734 Reduced 9.15%	2,260,525 $533 Million
Q1 2020 May 01, 2020	SELL	$182.24 - $241.7 $95.8 Million - $127 Million	-525,866 Reduced 17.45%	2,488,259 $504 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $47.6 Million - $61.2 Million	251,813 Added 9.12%	3,014,125 $727 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $42.2 Million - $50.6 Million	242,496 Added 9.62%	2,762,312 $535 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $17.4 Million - $20.4 Million	104,407 Added 4.32%	2,519,816 $464 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $36.9 Million - $41.6 Million	204,043 Added 9.23%	2,415,409 $459 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $71.5 Million - $83.4 Million	-400,662 Reduced 15.34%	2,211,366 $430 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $36.8 Million - $41.5 Million	-198,823 Reduced 7.07%	2,612,028 $541 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $6.6 Million - $7.41 Million	39,753 Added 1.43%	2,810,851 $519 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $10.1 Million - $11.8 Million	-59,392 Reduced 2.1%	2,771,098 $472 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $98.1 Million - $110 Million	581,356 Added 25.85%	2,830,490 $492 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $21.8 Million - $24.9 Million	-130,337 Reduced 5.48%	2,249,134 $419 Million
Q2 2017 Aug 14, 2017	BUY	N/A	72,102 Added 3.12%	2,379,471 $410 Million
Q1 2017 Nov 14, 2017	BUY	N/A	2,307,369	2,307,369 $379 Million

Others Institutions Holding AMGN

# of Institutions

2,929

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $164B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account